Cell MedX Corp News Releases

Cell MedX Corp. Closes Private Placement Financing

Tue, 19 Mar 2024 13:28:00 -0400

Vancouver, British Columbia--(Newsfile Corp. - March 19, 2024) - Cell MedX Corp. (OTC Pink: CMXC) ("Cell MedX", or the "Company") a biotech company focusing on the discovery, development and commercialization of therapeutic and non-therapeutic products that promote anti-aging and general wellness, announces that it has closed a non-brokered private placement offering (the "Offering") by issuing 2,500,000 units (each a "Unit") at US$0.03 per Unit for total gross proceeds of US$75,000. Each Unit...

Cell MedX Corp. Announces Resignation of Director

Wed, 28 Feb 2024 16:47:00 -0500

Vancouver, British Columbia--(Newsfile Corp. - February 28, 2024) - Cell MedX Corp. (OTC Pink: CMXC) ("Cell MedX", or the "Company") a biotech company focusing on the discovery, development and commercialization of therapeutic and non-therapeutic products that promote anti-aging and general wellness, announces the resignation of Brad Hargreaves from the Board of Directors of the Company. The resignation of Mr. Hargreaves was not due to any disagreement with the Company on any matter relating to...

Cell MedX Corp. Appoints Dr. George Adams as Chairman of the Board

Mon, 26 Feb 2024 09:15:00 -0500

Vancouver, British Columbia--(Newsfile Corp. - February 26, 2024) - Cell MedX Corp. (OTC Pink: CMXC) ("Cell MedX", or the "Company") a biotech company focusing on the discovery, development and commercialization of therapeutic and non-therapeutic products that promote anti-aging and general wellness, is pleased to announce the appointment by the board of directors of Dr. George Adams as Chairman of the Board.Dr. Adams has served on the board of directors of the Company since March 23, 2018 and...

Cell MedX Corp. Announces New CEO and Directors and Debt Settlement

Tue, 19 Dec 2023 14:24:00 -0500

Vancouver, British Columbia--(Newsfile Corp. - December 19, 2023) - Cell MedX Corp. (OTC Pink: CMXC) ("Cell MedX" or the "Company"), a biotech company focusing on the discovery, development and commercialization of therapeutic and non-therapeutic products that promote general wellness, announces that Mr. Dwayne Yaretz has resigned as Chief Executive Officer of the Company and Mr. Brad Hargreaves has resigned as VP of Technology and Operations. Mr. David Jeffs has been appointed as the new Chief...

Cell MedX Corp. Announces Full Revocation of British Columbia Cease Trade Order

Mon, 27 Nov 2023 13:16:00 -0500

Vancouver, British Columbia--(Newsfile Corp. - November 27, 2023) - Cell MedX Corp. ("Cell MedX" or the "Company") (OTC Pink: CMXC) announces that on November 22, 2023, the British Columbia Securities Commission (the "BCSC") issued an order revoking the Cease Trade Order previously issued by the Commission on October 11, 2022 (the "CTO"). The CTO was previously issued by the BCSC for Cell MedX failing to file audited financial statements and related management's discussion and analysis and an...

Cell MedX Corp. Appoints Audit Committee and Accepts Resignation of Chief Operating Officer

Thu, 09 Nov 2023 08:00:00 -0500

Vancouver, British Columbia--(Newsfile Corp. - November 9, 2023) - Cell MedX Corp. (OTC Pink: CMXC) ("Cell MedX" or the "Company"), a biotech company focusing on the discovery, development and commercialization of therapeutic and non-therapeutic products that promote general wellness, is pleased to announce that it has appointed Mr. Dwayne Yaretz, Mr. George Adams and Mr. Joao (John) da Costa as members of the Company's Audit Committee.The Company also announces that Mr. Joao da Costa has...